Hancock Whitney Corp Baxter International Inc Transaction History

Hancock Whitney Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	BUY	$37.88 - $43.77 $27,841 - $32,170	735 Added 5.42%	14,292 $610,000
Q4 2023 Feb 14, 2024	SELL	$31.71 - $38.95 $152,429 - $187,232	-4,807 Reduced 26.18%	13,557 $524,000
Q3 2023 Nov 13, 2023	BUY	$37.32 - $49.29 $19,033 - $25,137	510 Added 2.86%	18,364 $693,000
Q2 2023 Aug 10, 2023	BUY	$39.98 - $47.68 $713,802 - $851,278	17,854 New	17,854 $813,000
Q4 2018 Feb 15, 2019	SELL	$61.45 - $77.8 $964,089 - $1.22 Million	-15,689 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $2,262 - $2,488	-32 Reduced 0.2%	15,689 $1.21 Million
Q2 2018 Aug 14, 2018	SELL	$63.43 - $75.41 $6,152 - $7,314	-97 Reduced 0.61%	15,721 $1.16 Million
Q1 2018 May 15, 2018	BUY	$62.56 - $72.26 $301,226 - $347,931	4,815 Added 43.76%	15,818 $1.03 Million
Q4 2017 Feb 12, 2018	SELL	$61.45 - $66.05 $553,050 - $594,450	-9,000 Reduced 44.99%	11,003 $711,000
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $595 - $646	10 Added 0.05%	20,003 $1.26 Million
Q2 2017 Aug 11, 2017	BUY	N/A	19,993	19,993 $1.21 Million

980

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.1B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.